Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Polio Vaccine as Potential Protection Against COVID-19
NCT04445428Phase 4Completed
- Sponsor
- Bandim Health Project
- Start
- Jul 2020
- Primary completion
- Jan 2022
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of Oral polio vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Bandim Health Project. Primary endpoint: Mortality or Infectious Disease Causing Consultation or Admission at 6 months. Started Jul 2020; status: completed.
02
Drugs
Oral polio vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04445428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04445428.